When the recognition framework breaks - when canal disease in a Type 3 transformation zone goes uncurettaged, when atypical vessels get mistaken for pregnancy hyperemia, when CIN 2 in a 24-year-old gets ablated instead of observed - patients pay across decades of surveillance and, in the worst cases, in preventable cancer. This handbook delivers the Colposcopic Lesion Discriminator System - the structured framework that locks every recognition and management decision at the moment of care across cervical, vulvar, vaginal, and anal disease. Apply ASCCP 2019 risk-based management - work immediate and 5-year CIN 3+ thresholds at every encounter, with the expedited treatment criteria distilled to action Lock high-grade recognition - inner border, ridge sign, cuffed crypts, and coarse vascular patterns that separate CIN 2/3 from low-grade and metaplastic mimics Choose the right excision - match LEEP loop to TZ Type, identify when single-pass becomes top-hat, recognize the AIS scenario where cold knife cone wins Read the LAST framework - use p16 to disambiguate CIN 2 into HSIL or LSIL biology and let the biomarker drive treat-or-observe Manage the pregnant cervix - separate eversion, hyperemia, and decidual reaction from focal dysplasia and defer biopsy when indicated Extend to anal HSIL post-ANCHOR - apply colposcopy expertise to high-resolution anoscopy in persons living with HIV and other high-risk populationsFor OB/GYN residents, gynecologic oncology fellows, family medicine residents, and the nurse practitioners and physician assistants who perform colposcopy in any clinical setting. Buy the handbook now and commit to evidence-based colposcopy for every patient whose cervical disease lands on your schedule.